The Food and Drug Administration (FDA), on April 13, 2024, endorsed a mobile app designed to combat major depressive disorder, a condition that potentially affects a large number of American adults.
The app provides mental health support using cognitive behavioral therapy techniques. The FDA’s move may revolutionize mental health treatment, pointing towards more remote and digital platforms.
Following a study involving 386 diagnosed adults, results showed a reduction in depressive symptoms for those who used the app for six weeks. Positive changes included emotion management, better moods, increased energy, and alleviated anxiety.
The app is scheduled for prescription release in the summer of 2024 on iOS and Android devices. Exact details regarding the release date, cost, and insurance coverage are yet to be announced.
The app employs a six-week program of cognitive behavioral therapy lessons, exercises, and personalized feedback.
A digital approach to treating major depression
Post-program support is available through lesson reviews and a supportive user community.
Designed for individuals aged 22 and older diagnosed with depression, the app should be used alongside traditional therapies and prescribed medications. Essential features include cognitive behavioral therapy modules, relaxation techniques, and a mood diary.
Potential users must understand that this app is not a standalone solution. Transparent communication with healthcare providers regarding app usage allows for tailored treatment plans.
Prescription usage requires regular discussions with healthcare providers about depression symptoms and treatment strategies. Facilitating regular contact between patients and their doctors, the app fosters a holistic approach to managing depression.
Dr. Sanam Hafeez, director of Comprehend the Mind, acknowledges the app’s potential for symptom management but emphasizes that it shouldn’t replace professional diagnosis and treatment. Non-prescription apps may also positively impact depressive symptom reduction, but the effectiveness varies, and apps should always be used in consultation with a healthcare professional.
